Fighting To Stop Tuberculosis

Uploaded by NDdotEDU on 03.11.2012

Marvin Miller Ph.D.: This is the greatest life saver in the history of mankind. One
compound. This is the core structure of penicillin. Since its discovery in 1928, it has saved
countless of millions of lives. This is why we study organic chemistry. This is why we
do research, because one molecule can alter the course of humanity - and that is what
we are hoping we’ve done here.
Narrator: Through the creation of a unique molecular compound, Notre Dame Professor Dr.
Marvin Miller and his research team have made a significant scientific breakthrough in the
treatment of tuberculosis.
Miller: Almost one third of the world is infected with tuberculosis, and every 20 seconds someone
dies from this disease. It is a cruel illness that affects the most vulnerable, the sick
and the poor.
Garrett Moraski: In spite of this, it’s been over 40 years since a new tuberculosis
drug has been brought to market. The reason is simple, it wasn’t seen as economically
viable. But here at Notre Dame, these are the kind of challenges we look to take on.
Narrator: With the help of Eli Lilly & Company, Dr. Miller and his team are working to convert
their compound into an easy to use anti-tuberculosis pill that will be affordable to patients in
underdeveloped countries.
Dr. Gail Cassell: The world desperately needs new treatments for tuberculosis, and these
outstanding researchers at Notre Dame give us all new hope.
Moraski: Drug development is an arduous process. We have been working ten years on tuberculosis,
but to think that even one person might live because of what you have done - it is completely
worth it.
Narrator: The University of Notre Dame asks: What would you fight for?
Miller: Fighting to stop tuberculosis.
Moraski: We are the fighting Irish!